Perspective Therapeutics CATX
NYSE CATX
$3.22 -0.26 (-7.47%)
As of: Aug 20, 2026 · 3:59 PM EDT

Perspective Therapeutics (CATX) Receivables - Other (2010 - 2025)

Perspective Therapeutics (CATX) posted Receivables - Other of $10000.0 for Q4 2025, down 97.95% sequentially from $487000.0 in Q4 2024, and down 97.95% YoY from $487000.0 in Q4 2024.

Perspective Therapeutics (CATX) Receivables - Other (2010 - 2025) Analysis & Trends

Perspective Therapeutics has reported Receivables - Other for 16 years, with the latest figure at $10000.0 in Q4 2025.

  • Quarterly Receivables - Other fell 97.95% year-over-year to $10000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $10000.0 (down 97.95% YoY) and the FY2025 annual result came in at $10000.0, down 97.95% from the prior year.
  • Receivables - Other fell to $10000.0 in Q4 2025 per CATX's latest filing, from $487000.0 in the prior quarter.
  • Over five years, Receivables - Other peaked at $487000.0 in Q4 2024 and troughed at $2000.0 in Q4 2022.
  • A 5-year average of $93000.0 and a median of $13500.0 in 2022 frame the typical range for Receivables - Other.
  • The sharpest annual moves came in 2024 and 2025: Receivables - Other soared 4770.0% in 2024, then plunged 97.95% in 2025.
  • Over 5 years, Receivables - Other stood at $32000.0 in 2021, then plunged by 93.75% to $2000.0 in 2022, then soared by 400.0% to $10000.0 in 2023, then jumped by 4770.0% to $487000.0 in 2024, then slumped by 97.95% to $10000.0 in 2025.
  • According to Business Quant data, Receivables - Other over the past three periods registered $10000.0, $487000.0, and $10000.0 for Q4 2025, Q4 2024, and Q4 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn
10 Perspective Therapeutics 389.10 Mn 389.10 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 10,000.00
Dec 31, 2025 10,000.00
Dec 31, 2024 487,000.00
Dec 31, 2024 487,000.00
Dec 31, 2023 10,000.00
Dec 31, 2023 10,000.00
Dec 31, 2022 2,000.00
Dec 31, 2022 2,000.00
Jun 30, 2022 17,000.00
Jun 30, 2022 17,000.00
Jun 30, 2021 32,000.00
Jun 30, 2021 32,000.00
Jun 30, 2020 31,000.00
Jun 30, 2020 31,000.00
Jun 30, 2019 86,000.00
Jun 30, 2019 86,000.00
Jun 30, 2018 41,000.00
Jun 30, 2018 41,000.00
Jun 30, 2017 67,000.00
Jun 30, 2017 67,000.00